COX-2-IN-22 is a COX-2 inhibitor with potential therapeutic applications in neurodegenerative and inflammatory diseases due to its ability to cross the blood-brain barrier and its multi-target inhibitory activity against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), β-secretase, 5-lipoxygenase (LOX-5), and free radicals (as indicated by DPPH assay).